Results 71 to 80 of about 187,960 (311)

Analyzing Risks of Adverse Pregnancy Outcomes [PDF]

American Journal of Epidemiology, 2013
Approaches for analyzing the risks of adverse pregnancy outcomes have been the source of much debate and many publications. Much of the problem, in our view, is the conflation of time at risk with gestational age at birth (or birth weight, a proxy for gestational age). We consider the causal questions underlying such analyses with the help of a generic
Michael S, Kramer, Xun, Zhang, Robert W, Platt   +2 more
openaire   +2 more sources

Structure–Function Decoupling of the Sensorimotor and Default Mode Networks in Black Americans With MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background and Objectives Multiple sclerosis (MS) exhibits racially disparate rates of disease progression. Black people with MS (B‐PwMS) experience a more severe disease course than non‐Hispanic White people with MS (NHW‐PwMS). Here we investigated structural and functional connectivity as well as structure–function decoupling in the ...
Emilio Cipriano, Giacomo Boffa, Maria Petracca, Marta Ponzano, Nicole Graziano, Claire Wigley, Claire Riley, Jonathan Howard, Pietro Bontempi, Sylvia Klineova, Fred Lublin, Matilde Inglese   +11 more
wiley   +1 more source

Weight gain and dietary intake during pregnancy in industrialized countries - a systematic review of observational studies [PDF]

, 2011
Background: Gestational weight gain (GWG) above the recently recommended ranges is likely to be related to adverse pregnancy outcomes and therefore a challenge in industrialized countries.
Ina Streuling, Kries, Rüdiger von, Streuling, Ina, Rüdiger von Kries, Rosenfeld, Eva, Eva Rosenfeld, Britta Schukat, Beyerlein, Andreas, Schukat, Britta, Andreas Beyerlein   +9 more
core   +1 more source

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane, Giorgia Coratti, Chiara Cutrì, Antonio Varone, Riccardo Masson, Adele D'Amico, Valeria Sansone, Sonia Messina, Federica Ricci, Chiara Ticci, Claudio Bruno, Caterina Agosto, Francesca Benedetti, Antonella Pini, Sabrina Siliquini, Massimiliano Filosto, Alberto Zambon, Ilaria Bitetti, Maria Rosaria Manna, Claudia Dosi, Riccardo Zanin, Stefano Parravicini, Roberto De Sanctis, Giulia Stanca, Michela Catteruccia, Michele Tosi, Irene Mizzoni, Emilio Albamonte, Valentina Franchino, Maria Sframeli, Ilaria Cavallina, Elena Procopio, Michele Sacchini, Simone Morando, Noemi Brolatti, Federica Trucco, Gaia Scarpini, Elena Briganti, Beatrice Berti, Concetta Palermo, Daniela Leone, Stefano C. Previtali, Eugenio Mercuri, the ITASMAC working group   +43 more
wiley   +1 more source

Trial protocol OPPTIMUM : does progesterone prophylaxis for the prevention of preterm labour improve outcome? [PDF]

, 2012
Background Preterm birth is a global problem, with a prevalence of 8 to 12% depending on location. Several large trials and systematic reviews have shown progestogens to be effective in preventing or delaying preterm birth in selected high risk women ...
Sebire, Neil, Andrew Shennan, Thornton, S, Thornton, Steven, Petrou, Stavros, Marlow, N, Marlow, Neil, Robson Stephen, Tina Lavender, Neil Marlow, Neil Sebire, Robson, S, Sonia Whyte, Norman, Jane E., Norman, Jane E, Whyte, Sonia, Shennan, Andrew, Sebire Neil, Norrie John, Steven Thornton, Lavender Tina, Robson, Stephen, Stavros Petrou, Petrou, S, Lavender, Tina, Sebire, N, Thornton Steven, Marlow Neil, Whyte Sonia, John Norrie, Lavender, T, Stephen Robson, Bennett, Phillip R., Shennan, A, Sebire, Neil J., Bennett, Phillip, Bennett, P, Jane E Norman, Bennett Phillip, Petrou Stavros, Norrie, J, Norman, JE, Shennan Andrew, Phillip Bennett, Norman Jane E, Norrie, John, Whyte, S   +46 more
core   +1 more source

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

Annals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold, Krzysztof W. Selmaj, Regina Berkovich, Jeffrey A. Cohen, Giancarlo Comi, Eva K. Havrdová, James K. Sheffield, Hetal Desai, Chun‐Yen Cheng, Jon V. Riolo, Andrew Thorpe, Erik DeBoer, Bruce A. C. Cree   +12 more
wiley   +1 more source

The role of Ureaplasma urealyticum in adverse pregnancy outcome

, 1997
We investigated Ureaplasma urealyticum genital tract colonisation rates in an Australian population to determine whether colonisation was associated with adverse pregnancy outcome.
Timms, Peter, Cave, Donald, Farrell, David, Knox, Christine L, Eastment, Henry, Knox, Christine L.   +5 more
core   +1 more source

Adverse Pregnancy Outcome as A Result of Anaemia and Hyperglycemia with Special Focus on Time of Registration and Weight Gain During Pregnancy

National Journal of Community Medicine, 2014
Introduction: Adverse pregnancy outcome is a result of many factors related to mother that may act concomitantly. Weight gain during pregnancy is one of the important tools to assess course and outcome of pregnancy.
Shakila Mulla, Sulabha Akarte, Ranjit Mankeshwar, Shakeel Ansari   +3 more
doaj  

Perinatal substance use disorder: Examining the impact on adverse pregnancy outcomes

European Journal of Obstetrics & Gynecology and Reproductive Biology: X
Objective: Substance use disorder is a growing concern in the USA, especially among pregnant women. This study was undertaken to assess the impact of substance use disorder on adverse pregnancy outcomes using a nationwide sample of inpatient pregnancy ...
Alexandra S. Ragsdale, Noor Al-Hammadi, Travis M. Loux, Sabel Bass, Justine M. Keller, Niraj R. Chavan   +5 more
doaj   +1 more source

Safety and Tolerability of Givinostat: Evidence From Real‐World and Clinical Practice

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The aim of our study was to establish the prevalence of adverse events in a real‐world setting in boys living with Duchenne muscular dystrophy (DMD) treated with givinostat as part of an Expanded Access Program (EAP) in Italy. Methods The cohort included 90 ambulant boys, with age when treatment started between 6 and 23 years (mean ...
Marika Pane, Anna Capasso, Chiara Arpaia, Adele D’Amico, Emilio Albamonte, Federica Trucco, Maria Sframeli, Riccardo Masson, Francesca Magri, Luca Bello, Romina Venditti, Claudia Dosi, Michela Catteruccia, Michele Tosi, Claudio Bruno, Sonia Messina, Giacomo Comi, Elena Pegoraro, Valeria A. Sansone, Eugenio Mercuri   +19 more
wiley   +1 more source